|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 12, No. 4, 2002, pp. 52-53
|
Bioline Code: au02027
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Australasian Biotechnology (backfiles), Vol. 12, No. 4, 2002, pp. 52-53
en |
PHARMACEUTICAL DEVELOPMENT - WHY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ARE WORKING TOGETHER
Peter Devine
Abstract
Historically, pharmaceutical companies managed the entire drug development and production process, from inception to final product. However, today 20-30% of new drugs are biotechnology-derived, and over half of the drug leads undergoing preclinical or clinical research have been developed by biotechnology companies. So what has changed?
|
|
© Copyright 2002 - AusBiotech Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16
|
|